Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
10 July 2021 - 1677
Analysis of efficacy from STRIVE phase II trial of rezafungin treatment of candidaemia and/or invasive candidiasis: outcomes during initial days of treatment
Alex Soriano, A. Soriano (1), G.R. Thompson (2), J. Vazquez (3), P. Merino-Amador (4), A. Das (5), T. Sandison (5), P.G. Pappas (6)
09 July 2021 - 1672
Analysis of safety from STRIVE phase II Trial of rezafungin treatment of candidaemia and/or invasive candidiasis: assessment of adverse events and laboratory values
George R. Thompson, G.R. Thompson (1), A. Soriano (2), P.M. Honore (3), J.P. Horcajada (4), A. Das (5), T. Sandison (5), P.G. Pappas (6)
22 April 2018 - O0425
A phase-3 randomized, double-blind, multi-centre study to compare the safety and efficacy of oral omadacycline to oral linezolid for treating adult subjects with ABSSSI (OASIS-2 study)
Ella Ariza Heredia, W. O’Riordan, C. Cardenas, A. Sirbu, L. Garrity-Ryan, A. Das, P. Eckburg, A. Manley, J. Steenbergen, E. Tzanis, P. McGovern, E. Loh
21 April 2018 - P0271
Omadacycline gastrointestinal effects — an integrated safety analysis from the phase-3 ABSSSI and CABP studies
Shreya Singh, O. Cornely, L. Garrity-Ryan, A. Das, P. Eckburg, A. Manley, E. Tzanis, P. McGovern
21 April 2018 - P0272
Efficacy of omadacycline versus moxifloxacin in treating subjects from different geographic regions with community-acquired bacterial pneumonia (CABP)
Lynne Garrity-Ryan, L. Garrity-Ryan, C. Kirsch, A. Manley, E. Tzanis, J. Steenbergen, P. Eckburg, A. Das, P. McGovern
21 April 2018 - P0277
Lefamulin is non-inferior to moxifloxacin in adults with community-acquired bacterial pneumonia (CABP): the phase 3 lefamulin evaluation against pneumonia (LEAP 1) study
Steve Gelone, T. File, L. Goldberg, A. Das, C. Sweeney, J. Saviski, S. Gelone, E. Seltzer, G. Talbot, L. Gasink
21 April 2018 - P0276
Lefamulin demonstrates favorable safety and tolerability in adults with community-acquired bacterial pneumonia (CABP) in the phase-3 lefamulin evaluation against pneumonia (LEAP 1) study
Steve Gelone, T. File, L. Goldberg, A. Das, C. Sweeney, S. Gelone, J. Saviski, E. Seltzer, G. Talbot, L. Gasink
21 April 2018 - P0275
Omadacycline versus moxifloxacin in the treatment of adults with community-acquired bacterial pneumonia (CABP): efficacy analysis according to EMA requirements
Antoni Torres, A. Torres, L. Garrity-Ryan, C. Kirsch, J. Steenbergen, P. Eckburg, A. Das, A. Manley, E. Tzanis, P. McGovern
21 April 2018 - P0273
Effects of oral omadacycline versus oral linezolid on lesion size and local signs of ABSSSI in the phase-3 OASIS-2 study
Jasmine Coppens, W. O’Riordan, E. Shin, A. Sirbu, L. Garrity-Ryan, A. Das, P. Eckburg, A. Manley, E. Tzanis, P. McGovern
21 April 2018 - P0274
Efficacy of oral omadacycline versus linezolid for treating adult subjects with ABSSSI: analysis by infection type and pathogen in the OASIS-2 study
Matteo Bassetti, M. Bassetti, E. Armstrong, J. Steenbergen, A. Das, P. Eckburg, A. Sirbu, L. Garrity-Ryan, A. Manley, E. Tzanis, P. McGovern
21 April 2018 - P0278
Alternatives to the all-cause mortality (ACM) endpoint for studies of hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP)
Antoni Torres, G. Talbot, A. Das, A. Torres, J. Powers, S. cush, A. Dane, M. Wible, R. Echols, S. Cammarata, J. Rex, T. Fleming, J. Loutit, S. Hoffmann
12 April 2016 - O588
Effective use of antibiotic resistance gene databases for whole genome and metagenomic sequencing data
Anupam Das, Das Anupam, A. Das, X. Basil Britto, G. Cochrane, S. Kumar-Singh, F. Aarestrup, H. Goossens, S. Malhotra-Kumar
28 April 2013 - LB2964
Efficacy results from 2 Phase 3 pivotal studies in complicated skin and soft tissue (cSSTI) / acute bacterial skin and skin structure infection (ABSSSI) comparing tedizolid and linezolid
Johnna Simoes, E. Fang*, C. De Anda, A. Das, P. Prokocimer (San Diego, San Mateo, US)
02 April 2012 - LB2816
Comparison of tedizolid phosphate and linezolid in investigator’s assessment of clinical response in patients with cellulitis in United States and Europe from a phase 3 ABSSSI study
Brendan Hannah, C. De Anda*, E. Fang, A. Das, M.C. Morillo, P. Prokocimer (San Diego, San Francisco, US; Ascot, UK)
01 April 2012 - P1134
A study of microbial aetiology of catheter-associated urinary tract infection in intensive care unit and medical wards from a tertiary care teaching hospital in New Delhi, India
Sayantan Banerjee, S. Banerjee*, S.K. Prakash, M.K. Daga, R. Kumar, A. Das, R. Kaur (New Delhi, IN)
01 April 2012 - P1543
A study of antimicrobial resistance of bacterial isolates from catheter-associated urinary tract infection in intensive care unit and medical wards of a tertiary care teaching hospital in Delhi, India
Sayantan Banerjee, S. Banerjee*, S.K. Prakash, M.K. Daga, R. Kumar, A. Das, R. Kaur (New Delhi, IN)
31 March 2012 - P693
Assessment of two early-response outcome measures in a phase 2 clinical trial of the pleuromutilin BC-3781 in acute bacterial skin and skin structure infections
George Talbot, W. Prince, F. Obermayr, C. Lell, A. Das, G. Talbot* (Vienna, AT; San Francisco, Anna Maria, US)
31 March 2012 - P719
A randomised, double-blind, multicentre study to evaluate the efficacy and safety of oral solithromycin (CEM-101) compared to oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia
Prabhavathi Fernandes, D. Oldach*, K. Clark, J. Schranz, A. Das, C. Craft, D. Scott, B. Jamieson, P. Fernandes (Chapel Hill, San Francisco, US)
Loading ...
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.